CXCL8 and asthma: T2-low asthma is characterized by the activation of non-T2 inflammatory pathways, including helper T-lymphocytes type 1 (Th1) and/or Th17 cells, IL-6, IL-8, IL-17, and IL-22, and epithelial-derived cytokines [41,42].